Abstract is not required for Editorialis not required for Editorial (This page in not part of the published article.) International Journal of Case Reports and Images, Vol. 6 No. 8, August 2015. ISSN – [0976-3198] Int J Case Rep Images 2015;6(8):526–529. www.ijcasereportsandimages.com Rivera-Zambrano et al. 526 CASE REPORT OPEN ACCESS Chronic kidney disease and cerebral small vessel disease: A casual or causal cerebrorenal relationship? Marx Rivera-Zambrano, Adria Arboix, Maria-Jose Sanchez Recent studies show that individuals with progressive chronic kidney disease have a greater risk of cardiovascular events, hospitalization and death [1]. Chronic kidney disease (CKD) is prevalent in acute stroke patients with rates varying from 20–35% in ischemic stroke and from 20–46% in intracerebral hemorrhage [2, 3]. Previously, a higher four to ten times, prevalence of stroke in dialysis patients have been reported [3]. It can therefore be concluded that CKD is an established and emergent risk factor for cardiovascular disease in general and for cerebrovascular disease in particular. Chronic kidney disease is defined either by a decrease in the estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73 m2 or by the presence of albuminuria as a marker of an increased glomerular permeability [4]. It represents also a poor prognosis factor in patients with acute stroke and its presence has been associated with stroke severity and poor outcomes in ischemic and hemorrhagic stroke. A study reported that patients with CKD had a 49% greater risk of neurological deterioration during hospital stay and in-hospital mortality, and higher degree of disability at discharge according to the modified Rankin scale score of 2 or more than patients without CKD [5]. Greater risk of recurrence of non-cardioembolic stroke in CKD patients has also been reported [3]. This Marx Rivera-Zambrano1, Adria Arboix2, Maria-JoseSanchez3 Affiliations: 1Internal Medicine Department, Hospital Universitari Sagrat Cor. Hospital Universitari Sagrat Cor, University of Barcelona, Barcelona, Catalonia, Spain; 2Cerebrovascular Division, Neurology Department, Hospital Universitari Sagrat Cor, University of Barcelona, Barcelona, Catalonia, Spain; 3Library Department. Hospital UniversitariSagratCor, University of Barcelona, Barcelona, Catalonia, Spain. Corresponding Author: Adria Arboix, Barcelona, Catalonia, Spain, 08029; Tel.: 34 934948940; Fax: 34 934948906; Email: aarboix@hscor.com, Received: 03 June 2015 Published: 01 August 2015 EdiTO iAlS OPEN A CE S worse neurological prognosis may be caused by the presence in these patients of proteinuria and albuminuria, and both conditions are significantly associated with high levels of inflammatory cytokines and oxidative stress, inflammation and conditions promoting coagulation, potentially causing excessive vascular damage at stroke onset. These factors are also associated with accelerated atherosclerosis and endothelial dysfunction. Albuminuria is also predictive of hemorrhagic transformation of stroke [2]. We must also point out that CKD patients have both high thromboembolic and high bleeding risks and this has implications for deciding the optimal therapeutic strategy for primary or secondary prevention in these clinical conditions. Thus, non-vitamin K antagonist oral anticoagulants (novel oral anticoagulants) seem to be safer and more effective for patients with nonvalvular atrial fibrillation than warfarin, but cannot be given to patients with advanced CKD because the activity of these drugs is greatly affected by renal function [2, 6]. Intravenous thrombolysis is not contraindicated for patients with CKD but experts have limited experience with this treatment in these patients [6]. It is worth mentioning that kidney impairment is strongly associated with cerebral small vessel diseases (SVDs), which occur as asymptomatic lacunar infarcts (Figure 1) often resulting in classical lacunar syndromes (pure motor hemiparesis, pure sensory syndrome, sensorimotor stroke, ataxic hemiparesis or dysarthriaclumsy hand) or, less frequently, in atypical lacunar syndromes [7,8]. They also result in leukoaraiosis or white matter hyperintensities, silent lacunes, prominent or enlarged perivascular spaces and cerebral microbleeds [9]. One study reported that the volume of white matter lesions increased when eGFR decreased [10], and another showed that proteinuria had strong relation with both the presence and number of microbleeds [11]. This special relationship between CKD and cerebral SVDs is still unclear and warrant further investigation but is probably due to the fact that the vasoregulation of the microvasculature of the two organs (kidney and
Read full abstract